PARD3B and colorectal carcinoma: Using lentiviral CRISPR/Cas9 gene editing in CaCO-2 cells, we targeted Partitioning Defective 3-Like protein (Par3L), a crucial regulator of cell polarity and AMPK signaling that enhances CRC cell survival.